Webinar: Accelerating RIM System Compliance with AI and Sporify
Seamlessly deploy the latest innovations and recognize immediate value.
Webinar: The Rise of Agentic PV: AI that thinks, plans, and acts
Learn how Agentic AI is bringing a new era of innovation to pharmacovigilance.
The ArisGlobal marketing department spent time with Clint Wolfe, Chief Human Resources Officer. They discussed changes at ArisGlobal, working from home, how different areas of the globe are handling COVID-19 differently, and more.
South Korean Contract Research Organization, LSK, spoke in a webinar ...
There has been significant changes in the way the EMA expects MAHs to handle ICSRs from the new EudraVigilance system, creating additional work for already busy pharmacovigilance departments
Safety departments at Marketing Authorization Holders & Regulatory Authorities are ...
Safety is evolving rapidly. There is a major, emerging opportunity ...
As different regulatory authorities have different timelines for adoption of these standards, E2B(R2) E2B(R3) will have to coexist. But having to operate two solutions creates huge complexities, unless you find a solution compliant with both. ArisGlobal LifeSphere Safety MultiVigilance is the only drug safety database solution provider thus far to provide full compliance to E2B R2 and E2B R3 standards for both import and export.
LifeSphere Safety MultiVigilance (LSSMV) database system has auto-translation capabilities that can translate safety narratives from English to Chinese and vice versa using advanced machine-learning technology.
Artificial intelligence (AI), machine learning, deep learning, natural language processing ...
With up to 30-50% annual growth in adverse event cases, how ...
On June 9th, 2020 ArisGlobal held a webinar titled “Pharmacovigilance and ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved